Inventor
BURNETT DUANE A
US62 patents
⚠️ This page may combine multiple inventors who share the name “BURNETT DUANE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
35 patentsUSRE37721EMay 28, 2002
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP99 citations99
US5846966ADec 8, 1998
Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
SCHERING CORP171 citations99
US5656624AAug 12, 1997
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
SCHERING CORP115 citations97
US5744467AApr 28, 1998
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP77 citations96
US5698548ADec 16, 1997
Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
SCHERING CORP88 citations96
US5688787ANov 18, 1997
Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
SCHERING CORP90 citations96
US5633246AMay 27, 1997
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP91 citations96
US5624920AApr 29, 1997
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP88 citations96
US7208486B2Apr 24, 2007
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP16 citations93
US6664273B2Dec 16, 2003
Piperidine based MCH antagonists for treatment of obesity and CNS disorders
SCHERING CORP45 citations92
US6632933B2Oct 14, 2003
Use of azetidinone compounds
SCHERING CORP18 citations90
USRE42461EJun 14, 2011
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
SCHERING CORP7 citations84
US7482360B2Jan 27, 2009
Fused tetracyclic mGluR1 antagonists as therapeutic agents
SCHERING CORP15 citations84
US7368562B2May 6, 2008
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP10 citations84
US7235543B2Jun 26, 2007
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP13 citations84
US7109207B2Sep 19, 2006
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
SCHERING CORP13 citations83
US6593078B1Jul 15, 2003
Use of azetidinone compounds
SCHERING CORP11 citations80
US7459442B2Dec 2, 2008
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP3 citations63
US7192944B2Mar 20, 2007
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP4 citations63
US7030113B2Apr 18, 2006
Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
SCHERING CORP2 citations62
US7598259B2Oct 6, 2009
mGluR1 antagonists as therapeutic agents
SCHERING CORP2 citations61
US7214691B2May 8, 2007
2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
SCHERING CORP6 citations61
US7144696B2Dec 5, 2006
Use of azetidinone compounds
SCHERING CORP1 citations60
US6933107B2Aug 23, 2005
Use of azetidinone compounds
SCHERING CORP1 citations60
US7902157B2Mar 8, 2011
Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
SCHERING CORP1 citations52
US7741289B2Jun 22, 2010
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP0 citations52
US7732413B2Jun 8, 2010
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP0 citations52
US7378518B2May 27, 2008
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP0 citations52
US7368563B2May 6, 2008
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
SCHERING CORP0 citations52
US7211574B2May 1, 2007
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
SCHERING CORP1 citations52
US7687501B2Mar 30, 2010
Pyridothienopyridazinone derivatives as mGluR1 antagonists
SCHERING CORP2 citations51
US7504391B2Mar 17, 2009
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
SCHERING CORP1 citations51
US7989464B2Aug 2, 2011
mGluR1 antagonists as therapeutic agents
SCHERING CORP0 citations50
US7723020B2May 25, 2010
Use of azetidinone compounds
SCHERING CORP0 citations50
US7485648B2Feb 3, 2009
mGluR1 antagonists as therapeutic agents
SCHERING CORP1 citations50
WU WEN-LIAN
5 patentsUS9226927B2Jan 5, 2016
Gamma secretase inhibitors
WU WEN-LIAN8 citations83
US8664411B2Mar 4, 2014
Tetrahydropyranochromene gamma secretase inhibitors
WU WEN-LIAN8 citations82
US9499502B2Nov 22, 2016
5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use
WU WEN-LIAN3 citations72
US8933116B2Jan 13, 2015
Gamma secretase inhibitors
WU WEN-LIAN1 citations51
US9181236B2Nov 10, 2015
2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
WU WEN-LIAN1 citations46
MERCK SHARP & DOHME
3 patentsUS8987195B2Mar 24, 2015
HCV NS3 protease inhibitors
MERCK SHARP & DOHME9 citations80
US9365589B2Jun 14, 2016
C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME7 citations71
US9453034B2Sep 27, 2016
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME2 citations52
SCHERING PLOUGH CORP
2 patentsASBEROM THEODROS
2 patentsUS8067621B2Nov 29, 2011
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
ASBEROM THEODROS5 citations60
US8569521B2Oct 29, 2013
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
ASBEROM THEODROS2 citations59
AQUINNAH PHARMACEUTICALS INC
1 patentSASIKUMAR THAVALAKULAMGARA K
1 patentBURNETT DUANE A
1 patentShowing the top 50 of 62 patents by PatentIndex Score.